A researcher at Oregon State University who discovered that certain compounds in cannabis are able to block the virus responsible for COVID-19 from penetrating human cells said preclinical trials could take place within months.

Richard van Breemen, a researcher at Oregon State’s Global Hemp Innovation Center, College of Pharmacy, and Linus Pauling Institute, said preclinical trials consist of using animal models and cell cultures to determine the safety and effectiveness of promising drug candidates.